DiscGenics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:DiscGenics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11190
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DiscGenics Inc (DiscGenics) is a biotechnology company that develops advanced spinal therapeutics. The company develops therapies to treat patients with intervertebral disc diseases. It provides products such as Injectable Discogenic Cell Therapy (IDCT), developed for treating patients with moderately degenerated discs; and Surgical Discogenic Cell Therapy (SDCT), developed for treating patients with herniated discs. DiscGenics develops adult human disc stem cells within tissue engineering to develop new approaches. The company provides technology Discosphere which is a novel method used to efficiently isolate stem-like progenitor cells from human adult intervertebral disc tissues. DiscGenics is headquartered in Salt Lake City, Utah, the US.

DiscGenics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DiscGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
DiscGenics Inc, Medical Devices Deals, 2012 to YTD 2018 9
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
DiscGenics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
DiscGenics Raises USD14 Million in Series B Financing 11
Discgenics To Raise US$3 Million In Venture Financing 12
Partnerships 13
CTI Clinical Trial and Consulting Services Enter into Co-Development Agreement with DiscGenics 13
DiscGenics Inc – Key Competitors 14
DiscGenics Inc – Key Employees 15
DiscGenics Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
02/15/2018: Cryoport to Provide DiscGenics with Cutting Edge Cold Chain Logistics Support for its Phase 1/2 Trial 17
Product Approvals 18
Oct 03, 2017: DiscGenics Receives FDA Allowance of IND to Commence Clinical Study of its Degenerative Disc Disease Therapy 18
Clinical Trials 19
Mar 22, 2018: DiscGenics Presents Promising Preclinical Study Results at ORS 2018 19
Other Significant Developments 20
Feb 15, 2018: Cryoport to Provide DiscGenics With Cutting Edge Cold Chain Logistics Support for its Phase I/II Trial 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
DiscGenics Inc, Pharmaceuticals & Healthcare, Key Facts 2
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DiscGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DiscGenics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
DiscGenics Inc, Medical Devices Deals, 2012 to YTD 2018 9
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
DiscGenics Raises USD14 Million in Series B Financing 11
Discgenics To Raise US$3 Million In Venture Financing 12
CTI Clinical Trial and Consulting Services Enter into Co-Development Agreement with DiscGenics 13
DiscGenics Inc, Key Competitors 14
DiscGenics Inc, Key Employees 15

List of Figures
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
DiscGenics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[DiscGenics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VSB Holding GmbH-エネルギー分野:企業M&A・提携分析
    Summary VSB Holding GmbH (VSB), formerly WSB Neue Energien GmbH is a renewable energy company that offers solutions for renewable energy projects. The company offers services such as wind energy services, photovoltaics services, investments and wind park management. It provides wind energy services …
  • Herti AD:企業の戦略・SWOT・財務情報
    Herti AD - Strategy, SWOT and Corporate Finance Report Summary Herti AD - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • MOIL Limited:企業の戦略・SWOT・財務情報
    MOIL Limited - Strategy, SWOT and Corporate Finance Report Summary MOIL Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Illinois Municipal Electric Agency:企業の戦略的SWOT分析
    Illinois Municipal Electric Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Promimic AB:医療機器:M&Aディール及び事業提携情報
    Summary Promimic AB (Promimic) is a biomaterial company that develops and markets nano-thin surface modifications for all implant materials and geometries. The company offers thin HA surface modification for orthopedic and dental implants, which improves osseointegration and bone healing around inte …
  • Entravision Communications Corporation (EVC):企業の財務・戦略的SWOT分析
    Entravision Communications Corporation (EVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • leon-nanodrugs GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Leon-Nanodrugs GmbH (Leon-Nanodrugs) is a drug development company that discovers and develops nanotechnology based drug delivery systems. The company develops oral and parenteral products. Its products portfolio includes nanoparticles and drug-delivery-systems such as functionalized multila …
  • PT Supreme Cable Manufacturing & Commerce Tbk (SCCO):企業の財務・戦略的SWOT分析
    PT Supreme Cable Manufacturing & Commerce Tbk (SCCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Fcmb Group Plc:企業の戦略・SWOT・財務分析
    Fcmb Group Plc - Strategy, SWOT and Corporate Finance Report Summary Fcmb Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Centrica Plc (CNA):石油・ガス:M&Aディール及び事業提携情報
    Summary Centrica Plc (Centrica) is an integrated energy company. It carries out electricity generation through and combined cycle gas turbine (CCGT) power stations, and nuclear power plants through its stake in EDF Energy Nuclear Generation. Centrica secures and supply gas and electricity to homes a …
  • Aibel AS:企業の戦略的SWOT分析
    Aibel AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Bayer CropScience AG:企業のM&A・事業提携・投資動向
    Bayer CropScience AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bayer CropScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • LegoChem Biosciences Inc (141080)-製薬・医療分野:企業M&A・提携分析
    Summary LegoChem Biosciences Inc (LCB) is a drug company that research and develops small molecule drugs. The company’s services include joint and contract research, chemical library package, compound synthesis and sales, and screening services. Its screening services include metabolic stability, pl …
  • Environmental Container Systems, Inc.:企業の戦略・SWOT・財務情報
    Environmental Container Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Environmental Container Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Navistar International Corporation (NAV):企業の財務・戦略的SWOT分析
    Navistar International Corporation (NAV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Hera SpA (HER):企業の財務・戦略的SWOT分析
    Hera SpA (HER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Centamin Plc:企業の戦略・SWOT・財務情報
    Centamin Plc - Strategy, SWOT and Corporate Finance Report Summary Centamin Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Spectra Energy Partners LP (SEP):石油・ガス:M&Aディール及び事業提携情報
    Summary Spectra Energy Partners LP (Spectra Energy), a subsidiary of Enbridge Inc., is a master limited partnership operating in mid-stream energy. The company conducts transmission, storage and gathering of natural gas. It also carries out the transportation and storage of crude oil. Spectra Energy …
  • Costco Wholesale Corporation:企業の戦略・SWOT・財務情報
    Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report Summary Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Medworxx Inc-医療機器分野:企業M&A・提携分析
    Summary Medworxx Inc (Medworxx), a subsidiary of Aptean Inc is an information technology solution provider that offers software solutions for patient flow, compliance, and education. The company’s software products include patient throughput review software, clinical criteria software, forms and ass …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆